Quarterly Reports

Investors

CV Sciences operates two distinct divisions: pharmaceuticals and consumer products. These divisions are supported by our medical and scientific advisory board, and state‐of‐the art production facilities.

Quarterly Reports

Date	Form	Description	Pages
05/15/14	10-Q	Quarterly report pursuant to Section 13 or 15(d) Documents EX-31.1 EX-31.2 EX-32.1 EX-32.2 EX-99.1	27
04/24/14	10-Q/A	Quarterly report pursuant to Section 13 or 15(d) Documents EX-31.1 EX-32.1	28
04/24/14	10-Q/A	Quarterly report pursuant to Section 13 or 15(d) Documents EX-31.1 EX-32.1	26
04/24/14	10-Q/A	Quarterly report pursuant to Section 13 or 15(d) Documents EX-31.1 EX-32.1	25
11/21/13	10-Q/A	Quarterly report pursuant to Section 13 or 15(d)	4
11/14/13	10-Q	Quarterly report pursuant to Section 13 or 15(d) Documents EX-10.2 EX-31.1 EX-32.1 EX-99.1	37
08/13/13	10-Q	Quarterly report pursuant to Section 13 or 15(d) Documents EX-2.1 EX-3.1 EX-3.2 EX-31.1 EX-32.1 EX-99.1	48
05/30/13	10-Q/A	Quarterly report pursuant to Section 13 or 15(d) Documents EX-31.1 EX-32.1	22
05/20/13	10-Q	Quarterly report pursuant to Section 13 or 15(d) Documents EX-31.1 EX-32.1 EX-99.1	20
05/15/13	NT 10-Q	Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB	3